Compare VOR & EDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | VOR | EDN |
|---|---|---|
| Founded | 2015 | 1992 |
| Country | United States | Argentina |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Electric Utilities: Central |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.1B |
| IPO Year | 2021 | 2007 |
| Metric | VOR | EDN |
|---|---|---|
| Price | $19.85 | $14.13 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 10 | 2 |
| Target Price | ★ $39.00 | $38.50 |
| AVG Volume (30 Days) | ★ 794.6K | 147.3K |
| Earning Date | 10-30-2026 | 08-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $21.13 |
| Revenue Next Year | N/A | $22.69 |
| P/E Ratio | ★ N/A | $16.98 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $6.50 | $14.80 |
| 52 Week High | $26.00 | $36.70 |
| Indicator | VOR | EDN |
|---|---|---|
| Relative Strength Index (RSI) | 51.11 | 14.79 |
| Support Level | $17.44 | N/A |
| Resistance Level | $20.11 | $27.54 |
| Average True Range (ATR) | 1.24 | 0.78 |
| MACD | 0.12 | -0.29 |
| Stochastic Oscillator | 50.99 | 7.80 |
Vor Biopharma Inc is a clinical-stage biopharmaceutical company focused on developing novel therapies for the treatment of autoimmune diseases. Its program, telitacicept, is a potential first- and best-in-class dual BAFF/APRIL inhibitor designed to suppress the signaling pathways that drive the maturation, proliferation, and survival of harmful B cells, including self-reactive B cells, thereby reducing autoantibody production and preventing downstream tissue damage.
Empresa Distribuidora y Comercializadora Norte SA is engaged in the distribution and sale of electricity. The firm's concession area covers the northern portion of the city of Buenos Aires, mainly for residential, commercial, industrial, and public service.